State Policy


Eliminating cancer as a cause of death means coming together as a community to address how we can collectively work to improve precision medicine in cancer care at the policy level so that patients receive the right treatments at the right time, and have access to life-saving genetic screens and tests to better inform treatment decisions.

YOUR Cancer Precision Medicine Roundtables convene influential organizations and individuals in states across the country to meet with their respective policy makers and discuss barriers to precision medicine with a goal of identifying tangible policy measures that ultimately help support patients living with cancer.


Discussions focus on overcoming barriers to precision medicine access, emphasizing potential policy solutions across four key topics:



Precision medicines are quickly being approved, challenging health professionals and patients to stay abreast of new treatments and testing requirements to improve treatment decisions.

HCP Collaboration

HCP Collaboration

Key decisions regarding genetic sequencing often don't involve the entire treatment team, which can hinder uptake of novel technologies and diminish patient outcomes.



High standards for demonstrating clinical and economic utility can pose coverage and payment challenges for treatment informed by novel diagnostics.



Legacy informatics systems used by most hospitals are unable to manage the growing breadth and complexity of patient data, sometimes challenging clinicians to incorporate them into clinical practice.

Roundtable States

So far we have convened thought leaders to discuss precision medicine barriers in California, Illinois, Texas and New York. Click below to learn more about the proposed policy solutions discussed at each meeting.

How Does Precision Medicine Work?

See how advancements in diagnostic testing are improving outcomes and leading to more personalized treatments for people living with lung cancer.